Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 26 min ago
PreprintCC BY-NC-NDChemRxiv

Redox-Paired Activation of Sulfur Hexafluoride Enables Nucleophilic C(sp3)–F Bond Formation

4 affiliations
  1. 1Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Helmholtz Center for Infection Research (HZI
  2. 2Organic Chemistry – Biomimetic Catalysis
  3. 3Saarland University
  4. 4Pharma Science Hub

Abstract

Sulfur hexafluoride (SF6) is a potent greenhouse gas whose direct use as a fluorine source in organic synthesis remains underdeveloped. Here, we disclose complementary photoredox and electrochemical strategies for nucleophilic fluorinations with SF6, merging oxidative formation of carbocation intermediated from alkoxamines, carboxylic acids, or thiols with SF6 reduction, the latter providing fluoride for C(sp3)–F bond formation. The photochemical protocol efficiently converts electronrich substrates and tolerates a broad range of functional groups, whereas paired electrolysis extends the reaction to electronically deactivated substrates. Together, the two methods enable fluorination of diverse benzylic and aliphatic substrates, including late-stage fluorination of structurally complex derivatives of pharmaceuticals, natural products, and agrochemicals.

Related

  1. Activation of a STAT3/LATS1 Signaling Axis by Folate Receptor α Enables Breast Cancer Cells to Resist Physiological Ferroptotic Stress
    P. P. Ambegaokar, H. L. Goel, E. R. Karner +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Nucleophilic defluorination of PFAS under mild conditions
    Pallabita Basu, Saravanakumar Manickam, Rana Dalapati +4
    Communications ChemistryPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyNatureCrossrefEurope PMCPMC
  3. PD-1 and PD-L1 Expression in Inflammatory Bowel Disease: A Paired Immunohistochemical Study
    Harald Bagger-Jörgensen, Christian Thomsen, Klas Sjöberg
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Lipid and immune profiles in children with systemic juvenile idiopathic arthritis: a case-control study with paired longitudinal comparison of disease activity
    Translational pediatricsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Decision-support modelling for liver paired exchange integrating clinical thresholds and operational feasibility
    Mohammad Heydari, Yanglei Li, Victor Shi +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaCrossref
BibTeX
@misc{biswas2026redoxpaired,
  title = {{Redox-Paired Activation of Sulfur Hexafluoride Enables Nucleophilic C(sp3)–F Bond Formation}},
  author = {Aniruddha Biswas and Demetra Zambardino and Tanja Gulder},
  howpublished = {ChemRxiv},
  year = {2026},
  month = oct,
  doi = {10.26434/chemrxiv.15009734/v1},
  url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15009734/v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Redox-Paired Activation of Sulfur Hexafluoride Enables Nucleophilic C(sp3)–F Bond Formation
AU  - Aniruddha Biswas
AU  - Demetra Zambardino
AU  - Tanja Gulder
PY  - 2026
DA  - 2026/10/01
PB  - ChemRxiv
DO  - 10.26434/chemrxiv.15009734/v1
UR  - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15009734/v1
AB  - Sulfur hexafluoride (SF6) is a potent greenhouse gas whose direct use as a fluorine source in organic synthesis remains underdeveloped. Here, we disclose complementary photoredox and electrochemical strategies for nucleophilic fluorinations with SF6, merging oxidative formation of carbocation intermediated from alkoxamines, carboxylic acids, or thiols with SF6 reduction, the latter providing fluoride for C(sp3)–F bond formation. The photochemical protocol efficiently converts electronrich substrates and tolerates a broad range of functional groups, whereas paired electrolysis extends the reaction to electronically deactivated substrates. Together, the two methods enable fluorination of diverse benzylic and aliphatic substrates, including late-stage fluorination of structurally complex derivatives of pharmaceuticals, natural products, and agrochemicals.
ER  -